Cat.#: ACPP-1346
| Despition | GFAP Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1063 | Recombinant Human PCDH18 Protein (Fc Tag) (AC1063) | 50 µg | inquiry |
| ACPP-1724 | Human FGF13 Protein (AC1724) | 5 µg | inquiry |
| ACPP-1048 | Recombinant Human Butyrylcholinesterase Protein (6×His Tag) (AC1048) | 50 µg | inquiry |
| ACPP-1762 | Human SNAP25 Protein, His (AC1762) | 10 µg | inquiry |
| ACPP-1584 | Human Human Leptin Protein (AC1584) | 100 µg | inquiry |
| ACPP-1315 | GTP cyclohydrolase 1 Blocking Peptide (AC1315) | 250 µg | inquiry |
| ACPP-1659 | Human Visfatin Protein (AC1659) | 5 µg | inquiry |
| ACPP-1591 | Mouse VCAM1 Protein (AC1591) | 2 µg | inquiry |
| ACPP-1222 | ALDH1A1 Blocking Peptide (AC1222) | 250 µg | inquiry |
| ACPP-1360 | Human GAD65 Protein (AC1360) | 1 mg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.